Novel antibody discovery platform may inform Alzheimer’s and Parkinson’s research

In diseases like Parkinson’s and Alzheimer’s, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells. The process of proteins spontaneously clumping is called protein aggregation and researchers have developed novel methods to generate aggregate-specific antibodies as specific probes or modulators of the aggregation process.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup